BK vs CLDX · P/E 17, $94.14B cap vs rev $37.0K
The Bank of New York Mellon Corporation (BK) versus Celldex Therapeutics Inc (CLDX) — a side-by-side from cached financials, not a winner call.
The Bank of New York Mellon Corporation (BK) is a banks - diversified company listed on US.
Celldex Therapeutics Inc (CLDX) is a biotechnology company listed on US.
BK does not have a complete income-statement cache yet.
Latest reported CLDX revenue for 2026-06-30 was $37.0K. Net income was -$152.2M. CLDX currently screens at market cap $2.35B.
BK currently screens at market cap $94.14B and trailing P/E 17.0. CLDX currently screens at market cap $2.35B.
Not investment advice. Open the BK and CLDX stock pages for the full models.
Not investment advice.